nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bax345/BLyS: A novel, completely human fusion protein targeting malignant B cells and delivering a unique mitochondrial toxin
|
Lyu, Mi-Ae |
|
|
322 |
2 |
p. 159-168 |
artikel |
2 |
Crosstalk between NFkB and glucocorticoid signaling: A potential target of breast cancer therapy
|
Ling, Jun |
|
|
322 |
2 |
p. 119-126 |
artikel |
3 |
Development of a novel approach, the epigenome-based outlier approach, to identify tumor-suppressor genes silenced by aberrant DNA methylation
|
Kikuyama, Mizuho |
|
|
322 |
2 |
p. 204-212 |
artikel |
4 |
Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells
|
Yu, Xian-Jun |
|
|
322 |
2 |
p. 185-194 |
artikel |
5 |
How to treat CML patients in the tyrosine kinase inhibitors era? From imatinib standard dose to second generation drugs front-line: Unmet needs, pitfalls and advantages
|
Breccia, Massimo |
|
|
322 |
2 |
p. 127-132 |
artikel |
6 |
Human gastric cancer development with TNF-α-inducing protein secreted from Helicobacter pylori
|
Suganuma, Masami |
|
|
322 |
2 |
p. 133-138 |
artikel |
7 |
Insulin promotes proliferation, survival, and invasion in endometrial carcinoma by activating the MEK/ERK pathway
|
Wang, Yingmei |
|
|
322 |
2 |
p. 223-231 |
artikel |
8 |
NOP14 promotes proliferation and metastasis of pancreatic cancer cells
|
Zhou, Bin |
|
|
322 |
2 |
p. 195-203 |
artikel |
9 |
Regulation of thrombomodulin expression in prostate cancer cells
|
Menschikowski, Mario |
|
|
322 |
2 |
p. 177-184 |
artikel |
10 |
RETRACTED: MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5
|
Xu, Xue-Mei |
|
|
322 |
2 |
p. 148-158 |
artikel |
11 |
SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial–mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway
|
Li, Xuqi |
|
|
322 |
2 |
p. 169-176 |
artikel |
12 |
Synergistic antitumor efficacy of sequentially combined paclitaxel with sorafenib in vitro and in vivo NSCLC models harboring KRAS or BRAF mutations
|
Zhang, Xiang-Hua |
|
|
322 |
2 |
p. 213-222 |
artikel |
13 |
Targeting a cornerstone of radiation resistance: Cancer stem cell
|
Moncharmont, Coralie |
|
|
322 |
2 |
p. 139-147 |
artikel |